跳至主要内容
临床试验/NCT07696182
NCT07696182尚未招募不适用

VOYAGER CE Clinical Trial : Validation Of anatomY-specific Aortic Valve Implantation Guided by Software Using EncantoR

Abbott Medical Devices0 个研究点目标入组 150 人开始时间: 2026年11月30日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
150
主要终点
Composite of all-cause mortality or all strokes at 12 months post index

研究概览

简要总结

VOYAGER CE Clinical Study using the Encantor TAVI System.

详细描述

The VOYAGER CE trial is a prospective, single-arm, multi-center, pre-market clinical investigation designed to evaluate the safety and performance of the Encantor TAVI System. This clinical trial will enroll subjects who have symptomatic heart disease due to severe native calcific aortic stenosis and who are judged by a heart team to be appropriate for transcatheter valve replacement therapy.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject identified as appropriate for transcatheter heart valve intervention therapy for the treatment of symptomatic, severe aortic stenosis.
  • Subject is of legal age for consent (18 years old).
  • Willing to return for required follow-up visits and assessments

排除标准

  • Pregnant or nursing subjects.
  • Need for emergency surgery for any reason
  • Anatomic or comorbid conditions
  • Currently participating in an investigational drug or device study that has not reached the primary endpoint or may confound the results of this trial

结局指标

主要结局

Composite of all-cause mortality or all strokes at 12 months post index

时间窗: 12 months post index

Composite of all-cause mortality or all strokes

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验

Validation Of anatomY-specific Aortic Valve... | 临床试验